ABCAM PLC-SPON ADR (ABCM)
US0003802040 - ADR
ABCM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. ABCM scores excellent on profitability, but there are some minor concerns on its financial health. An interesting combination arises when we look at growth and value: ABCM is growing strongly while it also seems undervalued.
1. Profitability
1.1 Basic Checks
ABCM had positive earnings in the past year.
In the past year ABCM had a positive cash flow from operations.
ABCM had positive earnings in each of the past 5 years.
ABCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 0.64%, ABCM belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
The Return On Equity of ABCM (0.93%) is better than 93.86% of its industry peers.
ABCM has a better Return On Invested Capital (1.98%) than 94.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABCM is significantly below the industry average of 13.58%.
The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
ABCM's Profit Margin of 1.94% is amongst the best of the industry. ABCM outperforms 94.86% of its industry peers.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a Operating Margin of 8.70%. This is amongst the best in the industry. ABCM outperforms 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
ABCM has a better Gross Margin (72.69%) than 83.58% of its industry peers.
In the last couple of years the Gross Margin of ABCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
ABCM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ABCM has more shares outstanding than it did 1 year ago.
ABCM has a better debt/assets ratio than last year.
2.2 Solvency
ABCM has an Altman-Z score of 8.64. This indicates that ABCM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.64, ABCM belongs to the best of the industry, outperforming 85.41% of the companies in the same industry.
The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
ABCM has a Debt to FCF ratio of 19.99. This is amongst the best in the industry. ABCM outperforms 94.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
ABCM's Debt to Equity ratio of 0.30 is on the low side compared to the rest of the industry. ABCM is outperformed by 71.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
A Current Ratio of 1.26 indicates that ABCM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, ABCM is not doing good in the industry: 86.73% of the companies in the same industry are doing better.
ABCM has a Quick Ratio of 1.26. This is a bad value and indicates that ABCM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.98, ABCM is doing worse than 88.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
ABCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 402.64%, which is quite impressive.
Measured over the past years, ABCM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.30% on average per year.
The Revenue has grown by 17.70% in the past year. This is quite good.
The Revenue has been growing by 11.64% on average over the past years. This is quite good.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS growth Q2Q191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Revenue growth Q2Q23.3%
3.2 Future
Based on estimates for the next years, ABCM will show a very strong growth in Earnings Per Share. The EPS will grow by 40.12% on average per year.
The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.25. ABCM is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 49.32, ABCM can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ABCM is valued cheaper than 94.53% of the companies in the same industry.
ABCM is valuated expensively when we compare the Price/Forward Earnings ratio to 21.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
ABCM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ABCM is cheaper than 94.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ABCM is valued cheaper than 93.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
ABCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has an outstanding profitability rating, which may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
ABCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ABCAM PLC-SPON ADR
NASDAQ:ABCM (12/5/2023, 7:00:00 PM)
After market: 23.99 0 (0%)23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.49B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y
EPS growth Q2Q
EPS Next Y125.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y